Immunocore Holdings plc Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2021 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Immunocore Holdings plc quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2021 to Q4 2023.
  • Immunocore Holdings plc Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $83.1M, a 3.83% decline year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $83.1M -$3.31M -3.83% Dec 31, 2023 10-K 2024-02-28
Q4 2022 $86.4M -$1.43M -1.63% Dec 31, 2022 10-K 2024-02-28
Q4 2021 $87.9M Dec 31, 2021 10-K 2024-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.